A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Update Il y a 4 ans
Reference: NCT01562327

Woman and Man

  • | Country :
  • Argentina
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This multi-center, observational study will evaluate the clinical practice patterns, efficacy and safety of RoActemra/Actemra (tocilizumab) in participants with moderate to severe rheumatoid arthritis. Data will be collected from each eligible participant initiated on RoActemra/Actemra treatment by their treating physician according to local label for 6 months from start of treatment.


Inclusion criteria

  • Rheumatoid Arthritis

Links